arrowTo report an adverse event

arrowFor any other medical emergency or R&D questions


Choose site

Rottapharm | Madaus
is now part of Meda AB


The nutraceutic division represents a natural offshoot in R|M's research. The dietary supplements developed fall into the same therapeutic categories in which the group has a wealth of experience: the cardiovascular area with the product line Armolipid, gynecology with the product line Estromineral and Forgest and the osteo-articular area with the newly released, Fortilase. Recently, additional categories were included in the group’s expertise: systemic hair care and photo-protection with the product lines Biomineral and Carovit.